Prosthetic Valve Endocarditis: Clinical Trials

4 trials for Prosthetic Valve Endocarditis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 terminated, 1 unknown. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 31Terminated 1

Follow Prosthetic Valve Endocarditis: new trials by email Literature Review of Prosthetic Valve Endocarditis trials Research Report on Prosthetic Valve Endocarditis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REVIVE-FR Registry
TAVI-in-SAVR (Valve-in-Valve), THV-in-THV (Redo-TAVI), Surgical Explantation of a Failed Transcatheter Heart Valve - Bioprosthetic Valve Failure, Prosthetic Heart Valve Dysfunction
Not yet recruitingInstitut für Pharmakologie und Präventive Medizin2002027-03-152026-10-21
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
Rifampin, No rifampin - Staphylococcus Aureus Endocarditis, Prosthetic Valve Endocarditis
Phase 3TerminatedTodd C. Lee MD MPH FIDSA12025-11-102026-09-21
Evolution of PET Fixation With FDG at the End of Antibiotic Treatment of Infective Endocarditis on Valvular Prosthesis
FDG-PET at the end of treatment for IE - Prosthetic Valve Endocarditis
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris502025-04-172025-08-05
Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?
Aminoglycoside - Prosthetic Valve Endocarditis
UnknownAssiut University3002021-12-012022-07-13

Narrower conditions

Endocarditis (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)

Interventions

Aminoglycosides (1)  ·  Conservative Treatment (1)  ·  Practice Management, Medical (1)  ·  Rifampin (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Institut für Pharmakologie und Präventive Medizin (1)  ·  Todd C. Lee MD MPH FIDSA (1)

Countries

Canada (1)  ·  Egypt (1)  ·  France (1)

NIH funding

2025 (1)